The asparagine-linked oligosaccharide chains of glycoproteins can be processed to form a wide variety of structures. The Golgi complex is the main compartment involved in this processing. In mammalian cells the first enzyme acting along the Golgi processing pathway is mannosidase 1, whose action is a prerequisite for any further processing and which is inhibited by the mannose analog 1-deoxymannojirimycin (dMM). To have insights into the processing pathway in plant cells, we have studied the In vivo effect of dMM on the processing of the bean (Phaseolus vulgads) storage proteins phaseolin and phytohemagglutinin, two well characterized plant glycoproteins. Cotyledons obtained from developing seeds were labeled with radioactive leucine, glucosamine, or fucose in the presence or absence of dMM. Treatment with dMM fully inhibited the acquisition of resistance to endo-#-N-acetylglucosaminidase H by phaseolin and phytohemagglutinin and the incorporation of fucose into protein. Furthermore, the apparent molecular weight of the polypeptides of phaseolin and phytohemagglutinin synthesized in dMM-treated cotyledons was consistent with the exclusive presence of oligommanose oligosaccharide chains which had not been processed in the Golgi complex. The inhibition of processing did not prevent exit from the Golgi complex, and most probably the storage proteins were correcty targeted to the protein bodies as indicated by the posttranslatonal polypeptide cleavage of phaseolin. These resuits indicate that the action of a mannosidase is the first obligatory step of Golgi-mediated processing also in a plant cell and, together with data obtained in other laboratories on the In vitro specificity of glycosidases and glycosyltransferases present in the Golgi complex of plant cells, support the hypothesis that the key early reactions in Golgi-mediated processing are similar if not identical in plants and mammals.
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The proteins that are synthesized on the ER of eukaryotic cells can be cotranslationally glycosylated at Asn residues present in the sequence Asn-X-Ser/Thr. The reaction consists of the transfer of an oligosaccharide chain (OS3) having the structure Glc3Man9GlcNac2 from its dolichol derivative to the Asn in the nascent glycoprotein. This oligosaccharide is then processed in a concerted, stepwise set of reactions catalyzed by several enzymes (reviewed in Ref. 18 pathway has branching points, some of which are probably cell type-specific. Furthermore, structures in which processing has been interrupted virtually at any step along the pathway have been found; these characteristics of the pathway thus make possible the formation of many different Asn-linked OS. Glycosylation changes the molecular characteristics of the proteins and this can influence protein stability, biological properties, and destiny (21) . The processing pathway has been most studied in mammalian cells: processing starts in the ER where the three Glc residues are removed by the sequential action of glucosidase I and II and one to three of the Man residues can be removed by an a-1,2 mannosidase. Glucosidase I and II have been identified also in plant cells (27) , while it is not yet known whether an ER mannosidase participates in glycoprotein processing in plants. Further processing requires transport to the Golgi complex, where most of the processing enzymes are located. The first enzyme acting in the Golgi complex in mammalian cells is the Golgi a-1,2-mannosidase (mannosidase I), which yields the structure Man5GlcNAc2: this is the substrate for GlcNAc transferase I which produces the GlcNAcMan5GlcNAc2 structure, the most important 'crossroad' of processing (18) . The mannose analog dMM inhibits mannosidase I in mammalian cells and glycoproteins synthesized in vivo in the presence of dMM have only OSs with the structure Man6_9GlcNAc2, indicating that the inhibition of mannosidase I blocks any further processing (1, 2, 12, 13) .
In vitro studies using a Golgi-enriched fraction from developing cotyledons of the common bean, Phaseolus vulgaris, and different glycopeptide acceptors revealed the presence of Golgi transferases with substrate specificities analogous to those of the enzymes present in mammalian cells (17) . Also, an a-mannosidase activity has been purified from the microsomal fraction of mung bean seedlings; in vitro experiments showed that this enzyme has substrate specificity similar to that of mammalian Golgi mannosidase I and is inhibited by dMM (26) . However To study the effect of dMM on protein synthesis and processing, developing cotyledons were incubated for 150 min in the presence of 5 mm dMM or in water as a control, then pulse labeled for 3 h with [3H]leucine and chased for 21 h to allow accumulation of radioactive protein in the protein bodies. Cotyledons treated with the inhibitor were maintained in 5 mM dMM throughout the 24 h pulse-chase. Proteins present in the soluble fraction and in the total membrane fraction were then analyzed by SDS-PAGE and fluorography (Fig. 1) . Storage proteins contained in the protein bodies, which break during homogenization (5) The top half of the cotyledons was discarded and the remainder was homogenized in a mortar with 0.5 mL/cotyledon of 100 mM Tris-Cl, 1 mM EDTA, pH 7.8 (buffer A), containing 12% (w/w) sucrose. Both the mortar and the homogenization solution were ice-cold. After centrifugation for 5 min at 10OOg at 4°C, the supernatant was layered over a dicontinuous sucrose gradient constituted by 6 mL ofbuffer A containing 16% (w/w) sucrose on top of 4 mL of buffer A containing 54% (w/w) sucrose. Centrifugation was for 90 min at 35,000 rpm at 4°C in a Beckman SW40 rotor. The load portion of the gradient (soluble fraction) and the organelles which sedimented on top ofthe 54% sucrose layer (membrane fraction) were then recovered. The soluble fraction contained PHA and PHSL released from the protein bodies, which had been disrupted during homogenization (5); the membrane fraction contained PHA and PHSL precursors present in the ER and in the Golgi complex. The two storage proteins were isolated as described (6), using monospecific antibodies covalently bound to Sepharose 4B (Pharmacia). Either total proteins present in each subcellular fraction or immunoisolated proteins were analyzed by SDS-PAGE and fluorography as described elsewhere (4) . Digestion of PHA and PHSL with endo H was done as described by Vitale et Fig. 1 ) which are synthesized on the ER and undergo virtually identical processing (25, 30, 31) . Cotranslationally a signal peptide is cleaved and two oligomannose OS are added. During passage of PHA through the Golgi complex the OS distal to the N terminus is processed: 4 to 6 mannose residues are removed and one residue of fucose and xylose added as well as probably two terminal N-acetylglucosamine residues. The terminal N-acetylglucosamine residues are removed after PHA has reached the protein bodies. The other OS is almost completely unprocessed and has a final structure Man8 9GlcNAc2. PHA was immunoprecipitated from the preparations shown in lanes 1 to 4 of Figure 1 (the immunoprecipitates are in lanes 5-8 of Fig. 1 ; most of PHA was recovered with the soluble fractions, but equal amounts of radioactivity were loaded in each lane to facilitate comparisons of the polypeptide patterns). A small amount of labeled PHA was recovered from the membrane fractions even after the long chase: in untreated cotyledons this PHA had a rather diffuse three-banded pattern in which the central band was the most intense (Fig. 1, lane 7) . This is because the membrane fraction contains both the ER and the Golgi complex: processing of the OS causes a decrease in the apparent mol wt of PHA polypeptides (this can be seen by comparing the patterns of glucosamine and fucose labeled PHA present in the membrane fraction of pulse-labeled cotyledons; see lanes 5-7 in Fig. 3 ) and therefore the pattern observed is the result of overlapping of polypeptides with unprocessed OS (present mainly in the ER) and processed OS (present in the Golgi complex). Mature PHA recovered with the soluble fraction (Fig. 1, lane 8) showed the two typical bands, with mobilities which do not exactly correspond with any ofthe components present in the membrane fraction: this is due to removal of the terminal N-acetylglucosamine residues, which further increases the mobility of PHA polypeptides (30, 31) . A completely different situation was observed in dMM-treated cotyledons: PHA from the membrane and the soluble fractions (lanes 5 and 6 in Fig. 1 ) had identical patterns, represented by two well-resolved bands. The electrophoretic mobilities were also identical to those of radioactive PHA polypeptides present after a short pulse in the membrane fraction of untreated cotyledons (not shown).
These results suggest that dMM blocked the processing of the OS distal from the N terminus. This hypothesis was first tested by examining PHA digested with endo H. Processing in the Golgi complex leads to acquisition ofendo H resistance (31) . Therefore, endo H digestion of PHA that accumulates in normal conditions leads to the removal of only one OS from each polypeptide (Fig. 2, lanes 2 and 4) Fig. 3 ).
PHSL was immunoprecipitated from the soluble fractions of the [3H]leucine pulse-chased cotyledons shown in Figure 1 ( Fig. 4) . As shown by the total protein patterns (Fig. 1) , dMM caused the accumulation of PHSL polypeptides with decreased mobilities with respect to normal PHSL (compare lanes 1 and 2 in Fig. 4) . The polypeptides accumulated in the presence ofdMM had a mobility higher than the polypeptides of the PHSL precursor isolated from the membrane fraction of control cotyledons pulse-labeled for 3 h with [3H]leucine (lane 3 in Fig. 4) . We interpret this to indicate that dMM caused the accumulation of PHSL which was not processed on the OS, but underwent post-translational removal of the short amino acid sequence because it reached the protein bodies. This hypothesis was tested by endo H digestion. Lane 4 in Figure 4 shows the pattern of PHSL isolated from the soluble fraction of control cotyledons and then digested with endo H. Deglycosylated polypeptides (arrowheads) and polypeptides with one OS (above each deglycosylated polypeptide) are produced, in a ratio of about 1:1. In PHSL a' and ," are much more abundant than a' and P3': our results therefore indicate that normally also some ofthe a" and (i" polypeptides have one processed OS, which is resistant to endo H digestion.
More than 95% of PHSL accumulated in dMM-treated cotyledons was totally susceptible to endo H (lane 5 in Fig. 4) , and deglycosylated polypeptides produced after digestion were indistinguishible in size from those obtained from normal PHSL (compare polypeptides marked by arrowheads in lanes 4 and 5 of Fig. 4) . Digestion of PHSL precursor present in the membrane fraction ofuntreated cotyledons (lane 6 in Fig.  4 ) produced deglycosylated polypeptides (more abundant) and once glycosylated polypeptides (less abundant). This is the result expected from digestion of the mixture of PHSL precursors present in the ER and in the Golgi complex. Also, deglycosylated polypeptides (arrowheads in lane 6) had modMM Inhibits Processing of the OS of PHSL, but Not Its Polypeptide Cleavage in the Protein Bodies PHSL is a trimeric protein which, at the polypeptide level, is composed by two size classes, a and ,B, of very similar polypeptides (14, 23) . Each polypeptide has two potential Nglycosylation sites and during synthesis on the ER the signal peptide is removed and each polypeptide is glycosylated with either one (a' and ft') or two (a" and fl") OS: this gives rise to a four-banded electrophoretic pattern on SDS-PAGE (6). The processing and the final structure of the OS of PHSL have recently been the subject of an extensive study (24) . The OS of a" and fl' do not appear to be processed during passage through the Golgi complex; however, when only the first Asn is glycosylated, as in a' and fl', the OS undergoes processing events very similar to those that occur on PHA. The only difference between PHA and PHSL is the absence of fucosylation on PHSL. In the protein bodies the polypeptides of PHSL also undergo the removal of a short amino acid sequence (5, 29) ; only a few amino acids are removed, but the exact site of cleavage has not yet been determined. Processing events occurring in the Golgi complex and in the protein bodies cause an increase in the electrophoretic mobility of phaseolin polypeptides, more pronounced in the case of a' and ,B', than of a" and f,". We have shown here that in the presence of dMM, PHA and PHSL do not acquire endo H resistance. Furthermore, PHA does not incorporate fucose. We assume that also incorporation of xylose is inhibited by dMM, both in PHA and PHSL, since xylose attachment confers endo H resistance to the OS (24) . Finally, the electrophoretic mobilities of the polypeptides of the two storage proteins synthesized in the presence of dMM are consistent with full inhibition of Golgimediated processing. We therefore propose that an enzyme analogous to mammalian mannosidase I is inhibited by dMM and that this causes a block in the processing of N-linked OS which occurs in the Golgi complex ofbean cotyledonary cells. The block obtained using dMM is different from the one obtained in the same cells due to the action of another mannosidase inhibitor, swainsonine. In mammalian cells, swainsonine inhibits mannosidase II, the enzyme which removes a-1,3-and a-1,6-linked mannoses thus converting GlcNAcMan5GlcNAc2 to GlcNAcMan3GlcNAc2 (28) . It has been shown that swainsonine most probably has the same effect on the processed OS ofPHA and that, as in mammalian cells (20) , the inhibitor does not prevent fucosylation in plant cells (10, 15) . Therefore, in bean cotyledonary cells two different mannosidases are acting on glycoproteins, apparently with the same specificities of mammalian mannosidase I and II. Our results obtained in vivo confirm and extend the work of other investigators who studied, in vitro, the substrate specificities of OS processing enzymes from bean cotyledons (17) . On the whole these studies strongly suggest that the reactions until the formation of GlcNAc2Man3GlcNAc2 are the same in plant and mammalian cells. Whether the subsequent reactions, which in mammalian cells occur mainly in the medial and trans cisternae of the Golgi complex (18) , occur along a similar pathway in the plant cells remains to be determined. The fact that addition of sialic acid has never been observed in plant glycoproteins may indicate that unlike the key early reactions, late reactions may be not widely conserved through evolution; late reactions appear to be specific for different animal cell types ( 16, 22) .
The storage proteins of bean cotyledons accumulate in the vacuolar protein bodies. Previous work from our laboratory has determined that glycosylation is not necessary for targeting of PHA to the protein bodies (3) . We have also shown that the post-translational processing ofthe polypeptide chains of PHSL can occur in the absence of OS (29) ; this processing takes place in the protein bodies and therefore, also for PHSL, glycosylation is not a prerequisite for correct intracellular targeting. Radioactive PHSL and PHA that accumulate after a pulse-chase labeling in the presence of dMM can be recovered with the soluble fraction which contains the proteins released from the protein bodies broken during homogenization. Furthermore, the polypeptide chains of this form of PHSL are post-translationally processed. These data strongly suggest that also abnormal glycosylation, due to the inhibition of processing of the OS that are normally destined to be extensively modified, does not interfere markedly with the intracellular transport of bean storage proteins.
